PharmaEssentia

6446 · TW · Healthcare / Drug Manufacturers - Specialty & Generic

1,380.00TWD+15.00 (+1.10%)

Price History

Full chart

Market Stats

Previous Close1,365.00

Open1,375.00

Day Range1,370.00 – 1,405.00

52-Week Range452.06 – 1,645.00

Volume3.70M

Market Cap481.28B

P/E (TTM)63.28

Forward P/E0.00

EPS18.41

Dividend Yield0.13%

Beta0.65

50-Day Avg1,291.00

200-Day Avg868.20

About

PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the treatment of solid tumor and immunology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Ko-Chung Lin Ph.D.
Employees0
HeadquartersNo. 3, Park Street, Taipei, Taiwan, 115, Taiwan
Websitehttps://www.pharmaessentia.com

Leadership

Dr. Ching-Leou Teng Ph.D.Chairman & Chief Pharmaceutical Officer
Mr. Ko-Chung Lin Ph.D.Founder, CEO, Chief Strategy Officer & Director
Mr. Chan-Kou Hwang Ph.D.President, GM & Director
Ms. Snow ChangSenior Director of Finance
Mr. Samuel LinVP and Head of Business Operations & Strategy
Xue Ling ZhangAccounting Supervisor
Ms. Lih-Ling Lin Ph.D.Chief Scientific Officer
Hsing-I ChenGeneral Counsel
Dr. Albert Qin M.D., Ph.D.Chief Medical Officer
Narihisa MiyachiHead of Japan Medical Affairs

Financials

Income Statement

Currency: TWD	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Revenue	53.10M	15.76M	28.47M	72.33M	13.36M	11.59M	5.47M	4.04M	26.24M	305.69M	557.26M	656.51M	2.88B	5.11B	9.73B	15.63B
Growth (%)	-	-70.33%	+80.70%	+154.01%	-81.53%	-13.23%	-52.77%	-26.27%	+550.21%	+1065.16%	+82.29%	+17.81%	+339.00%	+77.15%	+90.67%	+60.61%
Cost of Revenue	27.59M	24.29M	8.73M	5.09M	5.99M	42.05M	1.14M	-262.00K	28.39M	61.70M	373.32M	378.86M	812.29M	610.54M	1.18B	1.96B
Gross Profit	25.52M	-8.53M	19.74M	67.24M	7.37M	-30.47M	4.34M	4.30M	-2.16M	243.99M	183.93M	277.65M	2.07B	4.50B	8.56B	13.68B
Gross Margin	48.05%	-54.15%	69.33%	92.97%	55.17%	-262.89%	79.23%	106.49%	-8.23%	79.82%	33.01%	42.29%	71.82%	88.04%	87.91%	87.47%
Operating Expense	191.10M	198.27M	270.37M	668.31M	870.84M	831.39M	853.02M	893.77M	1.05B	1.09B	1.90B	3.10B	4.10B	6.41B	6.82B	8.75B
Operating Income	-165.58M	-206.81M	-250.62M	-601.07M	-863.47M	-861.85M	-848.68M	-889.48M	-1.05B	-849.22M	-1.72B	-2.82B	-2.03B	-1.91B	1.74B	4.93B
Operating Margin	-311.81%	-1312.38%	-880.19%	-831.05%	-6465.05%	-7436.82%	-15506.72%	-22043.99%	-4020.77%	-277.80%	-307.91%	-429.91%	-70.37%	-37.48%	17.83%	31.52%
EBITDA	-135.94M	-171.37M	-217.13M	-538.45M	-782.10M	-774.96M	-778.78M	-806.93M	-979.10M	-697.19M	-1.76B	-2.57B	-1.60B	-671.49M	3.38B	5.41B
EBITDA Margin	-255.99%	-1087.50%	-762.56%	-744.47%	-5855.83%	-6687.06%	-14229.45%	-19998.27%	-3731.89%	-228.07%	-316.73%	-392.07%	-55.36%	-13.15%	34.77%	34.58%
Net Income	-167.27M	-203.66M	-256.06M	-593.15M	-853.11M	-853.20M	-844.92M	-872.31M	-1.04B	-842.99M	-1.95B	-2.81B	-1.37B	-623.84M	2.97B	5.05B
Net Income Margin	-314.98%	-1292.40%	-899.26%	-820.09%	-6387.44%	-7362.16%	-15437.93%	-21618.54%	-3963.10%	-275.77%	-349.59%	-428.17%	-47.70%	-12.22%	30.46%	32.27%
R&D	145.21M	162.41M	234.11M	529.64M	765.28M	713.62M	685.84M	683.32M	785.71M	639.58M	922.38M	1.27B	1.43B	2.22B	2.59B	3.46B
R&D as % of Total Revenue	273.44%	1030.65%	822.18%	732.28%	5729.87%	6157.69%	12531.24%	16934.77%	2994.79%	209.22%	165.52%	193.87%	49.48%	43.56%	26.58%	22.14%
Interest Expense	24.00K	278.00K	5.75M	-	995.00K	1.90M	1.89M	1.75M	1.58M	-	8.26M	9.97M	18.53M	46.69M	22.19M	25.53M
Interest Expense % of Total Revenue	0.05%	1.76%	20.20%	-	7.45%	16.39%	34.51%	43.49%	6.03%	-	1.48%	1.52%	0.64%	0.91%	0.23%	0.16%

Balance Sheet

Currency: TWD	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Assets	310.16M	376.85M	733.74M	2.21B	1.66B	1.04B	4.50B	3.67B	2.81B	2.96B	5.53B	6.20B	15.33B	27.27B	31.06B	37.41B
Total Liabilities	65.97M	335.51M	184.22M	78.00M	190.25M	351.04M	228.15M	211.69M	333.08M	704.33M	1.61B	1.95B	3.19B	3.32B	3.59B	5.44B
Total Equity	244.19M	41.34M	549.52M	2.13B	1.47B	689.56M	4.27B	3.46B	2.47B	2.26B	3.92B	4.25B	12.14B	23.95B	27.47B	31.98B
Cash	61.19M	158.37M	340.69M	1.78B	1.13B	563.91M	4.04B	3.19B	2.17B	1.40B	3.20B	3.45B	10.30B	19.67B	21.05B	22.72B
Total Debt	16.69M	4.52M	22.31M	12.00K	114.02M	117.43M	111.67M	106.38M	99.95M	424.53M	646.80M	536.31M	1.57B	1.20B	965.47M	856.06M
Net Debt	-44.50M	-153.85M	-318.37M	-1.78B	-1.01B	-446.48M	-3.93B	-3.08B	-2.07B	-971.14M	-2.55B	-2.92B	-8.73B	-18.47B	-20.09B	-21.86B

Cash Flow

Currency: TWD	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	-75.42M	-165.45M	-193.56M	-285.17M	-599.15M	-526.91M	-657.17M	-790.48M	-826.84M	-945.02M	-1.46B	-2.46B	-1.51B	-705.56M	2.55B	5.28B
Investing Cash Flow	-15.64M	-27.79M	-171.60M	-83.78M	-185.64M	-48.44M	-29.00M	-61.66M	-188.81M	-237.86M	-302.20M	-78.18M	-1.24B	-486.65M	-1.33B	-2.48B
Financing Cash Flow	12.00M	290.42M	547.48M	1.81B	126.62M	13.31M	4.17B	-4.86M	-3.74M	411.49M	3.57B	2.81B	9.58B	10.45B	-185.21M	-499.94M
Capital Expenditure	15.57M	27.79M	168.89M	68.18M	175.27M	32.27M	25.71M	28.22M	150.75M	120.73M	207.51M	97.88M	320.75M	1.33B	903.50M	1.91B
Free Cash Flow	-90.99M	-193.24M	-362.45M	-353.35M	-774.43M	-559.19M	-682.88M	-818.70M	-977.60M	-1.07B	-1.66B	-2.56B	-1.83B	-2.03B	1.64B	3.37B
Dividends Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	366.17M
FCF to OCF	120.65%	116.80%	187.25%	123.91%	129.25%	106.13%	103.91%	103.57%	118.23%	112.78%	114.26%	103.98%	121.31%	288.17%	64.53%	63.83%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10.86%

Earnings

Report Date	May 12, 2016	Aug 12, 2016	Nov 11, 2016	May 12, 2017	Aug 11, 2017	Nov 14, 2017	May 15, 2018	Aug 13, 2018	Nov 12, 2018	May 15, 2019	Aug 14, 2019	Nov 14, 2019	Feb 26, 2020	May 15, 2020	Aug 13, 2020	Nov 15, 2020	May 13, 2021	Aug 16, 2021	Nov 15, 2021	May 16, 2022	Aug 12, 2022	Nov 14, 2022	May 11, 2023	Aug 9, 2023	Nov 9, 2023	Feb 26, 2024	May 13, 2024	Aug 13, 2024	Nov 14, 2024	Feb 25, 2025	May 11, 2025	Aug 12, 2025	Nov 4, 2025	Mar 3, 2026	May 14, 2026	Aug 12, 2026
EPS Estimate	-0.54	-0.81	-1.06	-0.69	-1.23	-0.95	-0.69	-0.84	-0.86	-0.88	-0.59	-1.00	-0.95	-0.71	-1.24	-1.21	-1.67	-2.06	-1.66	-2.55	-0.32	-1.13	-1.54	-1.13	-0.51	-1.03	0.77	0.98	2.23	3.21	2.44	3.16	3.89	3.97	3.83	6.23
EPS Actual	-0.71	-0.87	-0.86	-0.84	-0.76	-0.72	-0.86	-0.77	-0.90	-1.03	-0.75	-1.02	-0.32	-1.06	-0.75	-1.97	-2.14	-1.69	-2.19	-1.59	-0.80	-1.17	-1.98	-0.50	0.54	0.31	0.99	1.68	1.80	3.70	3.09	2.02	3.60	3.97	5.21	6.13
Surprise	-31.48%	-7.41%	18.87%	-21.74%	38.21%	24.21%	-24.64%	8.33%	-4.65%	-17.05%	-27.12%	-2.00%	66.32%	-49.30%	39.52%	-62.81%	-28.14%	17.96%	-31.93%	37.65%	-150.00%	-3.54%	-28.57%	55.75%	205.88%	130.10%	28.57%	71.43%	-19.28%	15.09%	26.64%	-36.08%	-7.46%	0.00%	36.03%	-1.61%
Timing	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	After-hours	-	After-hours	Pre-market	Pre-market	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap481.28B

Enterprise Value462.64B

Trailing P/E63.28

Forward P/E0.00

Price / Sales23.23

Price / Book13.20

EPS18.41

Book Value88.84

Revenue (TTM)20.75B

Gross Profit (TTM)18.86B

EBITDA8.14B

Profit Margin36.76%

Operating Margin45.99%

Return on Equity23.34%

Return on Assets12.95%

Shares Outstanding413.11M

Shares Float330.92M

Beta0.65

Dividend Yield0.13%

Dividend Rate1.49

Payout Ratio7.88%

Dividends

20261×

1.49Jul 9, 2026

20251×

0.89Aug 11, 2025

Stock Splits

Jul 9, 20261109.2778:1000
Sep 11, 20251109.731:1000